Literature DB >> 7509317

Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes.

E Lett1, S Gangloff, M Zimmermann, D Wachsmann, J P Klein.   

Abstract

To develop a general model of polysaccharide-peptide vaccine, we have investigated the efficiency of linear peptides derived from protein SR, and adhesin of the I/II protein antigen family of oral streptococci, to act as carriers for two T cell-independent polysaccharides: serogroup f polysaccharide from Streptococcus mutans OMZ 175 (poly f) and Saccharomyces cerevisiae mannan. Peptide 3 (YEKEPTPPTRTPDQ) and peptide 6 (TPEDPTDPTDPQDPSS), accessible on the native SR protein as demonstrated by their reactivity in enzyme-linked immunosorbent assays with rat antisera raised against protein SR, correspond to immunodominant regions of SR. Peptide 3 contains at least one B- and one T-cell epitope, as demonstrated by its ability to induce peptide- and SR-specific antibody responses without any carrier and to stimulate the proliferation of rat lymph node cells primed either with free peptide or native SR, whereas peptide 6 contains only B-cell epitope(s). Peptide 3 was then covalently coupled though reductive amination to either poly f or mannan, and peptide 6 was coupled to poly f. Subcutaneous immunizations of rats with poly f-peptide 3 or mannan-peptide 3 conjugates produced a systemic immunoglobulin M (IgM) and IgG antibody response, and the elicited antibodies reacted with free poly f or mannan, peptide 3, protein SR, and S. mutans or S. cerevisiae whole cells. Rats immunized with poly f-peptide 6 did not develop any antipeptide or anti-SR response. Furthermore, a booster immunization of animals with poly f-peptide 3 or mannan-peptide 3 conjugates induced high titers of anti-peptide 3, anti-poly f, and antimannan antibodies, which occurred quickly. The response is anamnestic for the peptide and the polysaccharides and is characterized by an Ig switch from IgM to IgG. The data presented here confirm that the presence of B- and T-cell epitopes is necessary to induce an anamnestic antipeptide response and that a peptide containing relevant B- and T-cell epitopes can act as a good carrier in improving an antipolysaccharide anamnestic immune response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509317      PMCID: PMC186184          DOI: 10.1128/iai.62.3.785-792.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  Molecular mimicry as a mechanism for virus-induced autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  A B cell-, T cell-linked epitope located on the adhesin of Mycoplasma pneumoniae.

Authors:  E Jacobs; R Röck; L Dalehite
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli.

Authors:  S W Hunter; H Gaylord; P J Brennan
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

Review 4.  Polysaccharide-protein conjugates: a new generation of vaccines.

Authors:  J B Robbins; R Schneerson
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

5.  Molecular characterization of a surface protein antigen gene from serotype c Streptococcus mutans, implicated in dental caries.

Authors:  N Okahashi; C Sasakawa; M Yoshikawa; S Hamada; T Koga
Journal:  Mol Microbiol       Date:  1989-05       Impact factor: 3.501

6.  Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod.

Authors:  M Monsigny; C Petit; A C Roche
Journal:  Anal Biochem       Date:  1988-12       Impact factor: 3.365

7.  Purification and characterization of the expression product of the sr gene of Streptococcus mutans OMZ 175.

Authors:  J A Ogier; A Pini; P Sommer; J P Klein
Journal:  Microb Pathog       Date:  1989-03       Impact factor: 3.738

8.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

9.  Structure of the serotype f polysaccharide antigen of Streptococcus mutans.

Authors:  D G Pritchard; S M Michalek; J R McGhee; R L Furner
Journal:  Carbohydr Res       Date:  1987-08-15       Impact factor: 2.104

10.  A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus.

Authors:  R A Ezekowitz; M Kuhlman; J E Groopman; R A Byrn
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Resistance exercise overtraining and overreaching. Neuroendocrine responses.

Authors:  A C Fry; W J Kraemer
Journal:  Sports Med       Date:  1997-02       Impact factor: 11.136

2.  Passive immunization with bovine milk containing antibodies to a cell surface protein antigen-glucosyltransferase fusion protein protects rats against dental caries.

Authors:  Morihide Mitoma; Takahiko Oho; Naoko Michibata; Kaoru Okano; Yutaka Nakano; Masataka Fukuyama; Toshihiko Koga
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

Authors:  V Apostolopoulos; G A Pietersz; B E Loveland; M S Sandrin; I F McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 4.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

Authors:  E AlonsoDeVelasco; A F Verheul; J Verhoef; H Snippe
Journal:  Microbiol Rev       Date:  1995-12

5.  Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.

Authors:  E A de Velasco; D Merkus; S Anderton; A F Verheul; E F Lizzio; R Van der Zee; W Van Eden; T Hoffman; J Verhoef; H Snippe
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

6.  Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes.

Authors:  E Lett; C Klopfenstein; J P Klein; M Schöller; D Wachsmann
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

7.  Defining antibody targets in Streptococcus oralis infection.

Authors:  J P Burnie; W Brooks; M Donohoe; S Hodgetts; A al-Ghamdi; R C Matthews
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.